Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MERIT MEDICAL SYSTEMS INC Director's Dealing 2021

Sep 17, 2021

31049_dirs_2021-09-17_cdaed805-b239-4441-bfd3-c60f91818225.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-09-15

Reporting Person: Ward Lynne (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-15 Common Stock, No Par Value M 14867 $34.46 Acquired 21969 Direct
2021-09-15 Common Stock, No Par Value S 9470 $71.83 Disposed 12499 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-15 Non-qualified stock options (right to buy) $34.46 M 14867 Disposed 2026-08-28 Common Stock (14867) Direct

Footnotes

F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.538 to $72.02, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F2: The total reported in Column 5 of Table I includes 4,188 fully-vested restricted stock units and 2,914 restricted stock units that vest on June 17, 2022. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date.

F3: Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.